In order to examine whether the ability of NRF2 to drive AKR gene transcription is ubiquitous in human cell types of different origin, we have measured the expression of mRNA and protein for these targets in a panel of cultured cell lines (mostly tumour-derived) in both basal and induced states. The gene discussed is NFE2L2; the disease is neoplasm.